<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Mol. Biosci.</journal-id>
<journal-title>Frontiers in Molecular Biosciences</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Mol. Biosci.</abbrev-journal-title>
<issn pub-type="epub">2296-889X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">780284</article-id>
<article-id pub-id-type="doi">10.3389/fmolb.2021.780284</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Molecular Biosciences</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Impact of Deleterious Mutations on Structure, Function and Stability of Serum/Glucocorticoid Regulated Kinase 1: A Gene to Diseases Correlation</article-title>
<alt-title alt-title-type="left-running-head">AlAjmi et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">Deleterious Mutations in SGK1</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>AlAjmi</surname>
<given-names>Mohamed F.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/605291/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Khan</surname>
<given-names>Shama</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Choudhury</surname>
<given-names>Arunabh</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1458421/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mohammad</surname>
<given-names>Taj</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/676201/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Noor</surname>
<given-names>Saba</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/389640/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hussain</surname>
<given-names>Afzal</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/414473/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lu</surname>
<given-names>Wenying</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/843219/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Eapen</surname>
<given-names>Mathew Suji</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chimankar</surname>
<given-names>Vrushali</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hansbro</surname>
<given-names>Philip M</given-names>
</name>
<xref ref-type="aff" rid="aff7">
<sup>7</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/672127/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sohal</surname>
<given-names>Sukhwinder Singh</given-names>
</name>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1292280/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Elasbali</surname>
<given-names>Abdelbaset Mohamed</given-names>
</name>
<xref ref-type="aff" rid="aff8">
<sup>8</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1517882/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Hassan</surname>
<given-names>Md. Imtaiyaz</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/256640/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<label>
<sup>1</sup>
</label>Department of Pharmacognosy, College of Pharmacy, King Saud University, <addr-line>Riyadh</addr-line>, <country>Saudi Arabia</country>
</aff>
<aff id="aff2">
<label>
<sup>2</sup>
</label>Drug Discovery and Development Centre (H3D), University of Cape Town, <addr-line>Cape Town</addr-line>, <country>South Africa</country>
</aff>
<aff id="aff3">
<label>
<sup>3</sup>
</label>Department of Computer Science, Jamia Millia Islamia, <addr-line>New Delhi</addr-line>, <country>India</country>
</aff>
<aff id="aff4">
<label>
<sup>4</sup>
</label>Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, <addr-line>New Delhi</addr-line>, <country>India</country>
</aff>
<aff id="aff5">
<label>
<sup>5</sup>
</label>Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, <addr-line>Launceston</addr-line>, <addr-line>TAS</addr-line>, <country>Australia</country>
</aff>
<aff id="aff6">
<label>
<sup>6</sup>
</label>Centre for Inflammation, Centenary Institute and University of Technology Sydney, School of Life Sciences, Faculty of Science, <addr-line>Sydney</addr-line>, <addr-line>NSW</addr-line>, <country>Australia</country>
</aff>
<aff id="aff7">
<label>
<sup>7</sup>
</label>Priority Research Centre for Healthy Lungs and Hunter Medical Research Institute, The University of Newcastle, <addr-line>Newcastle</addr-line>, <addr-line>NSW</addr-line>, <country>Australia</country>
</aff>
<aff id="aff8">
<label>
<sup>8</sup>
</label>Clinical Laboratory Science, College of Applied Medical Sciences-Qurayyat, Jouf University, <addr-line>Sakakah</addr-line>, <country>Saudi Arabia</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/676789/overview">Paolo Marcatili</ext-link>, Technical University of Denmark, Denmark</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/921766/overview">Edoardo Milanetti</ext-link>, Sapienza University of Rome, Italy</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/920474/overview">Timir Tripathi</ext-link>, North Eastern Hill University, India</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Abdelbaset Mohamed Elasbali, <email>aeelasbali@ju.edu.sa</email>; Md. Imtaiyaz Hassan, <email>mihassan@jmi.ac.in</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Biological Modeling and Simulation, a section of the journal Frontiers in Molecular Biosciences</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>03</day>
<month>11</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>8</volume>
<elocation-id>780284</elocation-id>
<history>
<date date-type="received">
<day>24</day>
<month>09</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>10</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2021 AlAjmi, Khan, Choudhury, Mohammad, Noor, Hussain, Lu, Eapen, Chimankar, Hansbro, Sohal, Elasbali and Hassan.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>AlAjmi, Khan, Choudhury, Mohammad, Noor, Hussain, Lu, Eapen, Chimankar, Hansbro, Sohal, Elasbali and Hassan</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<abstract>
<p>Serum and glucocorticoid-regulated kinase 1 (SGK1) is a Ser/Thr protein kinase involved in regulating cell survival, growth, proliferation, and migration. Its elevated expression and dysfunction are reported in breast, prostate, hepatocellular, lung adenoma, and renal carcinomas. We have analyzed the SGK1 mutations to explore their impact at the sequence and structure level by utilizing state-of-the-art computational approaches. Several pathogenic and destabilizing mutations were identified based on their impact on SGK1 and analyzed in detail. Three amino acid substitutions, K127M, T256A, and Y298A, in the kinase domain of SGK1 were identified and incorporated structurally into original coordinates of SGK1 to explore their time evolution impact using all-atom molecular dynamic (MD) simulations for 200&#xa0;ns. MD results indicate substantial conformational alterations in SGK1, thus its functional loss, particularly upon T256A mutation. This study provides meaningful insights into SGK1 dysfunction upon mutation, leading to disease progression, including cancer, and neurodegeneration.</p>
</abstract>
<kwd-group>
<kwd>serum/glucocorticoid regulated kinase 1</kwd>
<kwd>deleterious mutations</kwd>
<kwd>single amino acid substitutions</kwd>
<kwd>molecular dynamics simulation</kwd>
<kwd>essential dynamics</kwd>
</kwd-group>
<contract-sponsor id="cn001">Indian Council of Medical Research<named-content content-type="fundref-id">10.13039/501100001411</named-content>
</contract-sponsor>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Cancer progression is the result of malfunction at multiple cellular levels, including abnormal gene expression, metabolic conditions, abnormal signal transduction, epithelial to mesenchymal transition, genetic, and epigenetic alterations (<xref ref-type="bibr" rid="B52">Sekido, 2010</xref>; <xref ref-type="bibr" rid="B33">Mahmood et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B32">Lu et&#x20;al., 2020</xref>). Alterations at genomic and proteomic levels cause significant changes to protein structure and function, resulting in the onset and progression of many complex diseases, such as cancer and neurodegeneration (<xref ref-type="bibr" rid="B6">Baak et&#x20;al., 2003</xref>). Serum/glucocorticoid regulated kinase 1 (SGK1) is a member of the AGC family of Serine/Threonine protein kinases that regulate the survivability and growth of cells (<xref ref-type="bibr" rid="B29">Lang et&#x20;al., 2010</xref>). It is involved in regulating cell cycle progression, proliferation, differentiation and apoptosis, and is associated with the onset and progression of various cancers in humans (<xref ref-type="bibr" rid="B51">Sang et&#x20;al., 2021</xref>). Its elevated expression and dysfunction are linked with multiple pathological conditions, including hypertension, ischemia, diabetic neuropathy, trauma, and neurodegenerative diseases (<xref ref-type="bibr" rid="B19">Eapen et&#x20;al., 2019</xref>). SGK1 is acutely regulated at various levels, including gene transcription and post-translationally by phosphorylation and ubiquitination. It is expressed in several tissues, including the spleen, thymus, bone marrow, breast, prostate, and oral epithelial (<xref ref-type="bibr" rid="B19">Eapen et&#x20;al., 2019</xref>).</p>
<p>SGK1 remains under strict transcriptional control even with various external stimuli such as cell stress and hormones, such as glucocorticoids and mineralocorticoids (<xref ref-type="bibr" rid="B41">O&#x2019;Keeffe et&#x20;al., 2013</xref>). It is encoded by the <italic>SGK1</italic> gene localized on chromosome 6 in the region 6q23 consisting of 148,867 bases with 14 coding exons (<xref ref-type="bibr" rid="B59">Waldegger et&#x20;al., 1998</xref>). The protein comprises 431 amino acids with a molecular mass of &#x223c;49&#xa0;kDa (<xref ref-type="bibr" rid="B60">Zhao et&#x20;al., 2007</xref>). The active site (proton acceptor) and ATP binding site of SGK1 are located at Asp222 and Lys127, respectively, (<xref ref-type="bibr" rid="B60">Zhao et&#x20;al., 2007</xref>). Most of the SGK1 structure has a common kinase fold, but the structure near its active site is unique compared to other kinases, and the main difference is near the ATP binding site (<xref ref-type="bibr" rid="B60">Zhao et&#x20;al., 2007</xref>). This is crucial for its functional activity, and any structural alteration at the ATP binding site can cause SGK1 dysfunction, which may lead to disease progression.</p>
<p>A single amino acid substitution or naturally occurring mutations are associated with several complex diseases, including cancers. Deleterious mutations at the genomic and/or proteomic level have significant impacts on human health. These mutations in SGK1, especially near its active site region, especially at ATP binding site, cause significant structural alterations and its dysfunction, which may promote disease progression (<xref ref-type="bibr" rid="B56">Snyder et&#x20;al., 2002</xref>; <xref ref-type="bibr" rid="B9">Boehmer et&#x20;al., 2003</xref>; <xref ref-type="bibr" rid="B22">Henke et&#x20;al., 2004</xref>). There are numerous reports of several naturally occurring mutations in SGK1, but their roles in pathogenesis at the structural level have not been widely studied (<xref ref-type="bibr" rid="B26">Kobayashi and Cohen, 1999</xref>; <xref ref-type="bibr" rid="B56">Snyder et&#x20;al., 2002</xref>). Biophysics-based computational methods are valuable in studying the impact of mutations on protein structure and function, and there is intense current interest in such studies (<xref ref-type="bibr" rid="B2">Amir et&#x20;al., 2019a</xref>; <xref ref-type="bibr" rid="B3">Amir et&#x20;al., 2019b</xref>; <xref ref-type="bibr" rid="B14">Choudhury et&#x20;al., 2021</xref>; <xref ref-type="bibr" rid="B21">Habib et&#x20;al., 2021</xref>).</p>
<p>Several methods have been developed to identify deleterious or disease-causing mutations within human protein sequences. These methods predict the deleteriousness of an amino acid substitution on the basis of physicochemical properties, structure, and cross-species conservation analysis (<xref ref-type="bibr" rid="B38">Ng and Henikoff, 2006</xref>; <xref ref-type="bibr" rid="B15">Chun and Fay, 2009</xref>). Identification of deleterious mutations in an individual has the potential to influence both the prevention and personalized interventions in disease.</p>
<p>Here, we performed an in-depth analysis of genomic and proteomic alterations in SGK1 using state-of-the-art computational approaches (<xref ref-type="bibr" rid="B14">Choudhury et&#x20;al., 2021</xref>; <xref ref-type="bibr" rid="B21">Habib et&#x20;al., 2021</xref>; <xref ref-type="bibr" rid="B58">Umair et&#x20;al., 2021</xref>). We examined a range of mutations and characterized their deleterious impact on the structure and function of SGK1, which may contribute to disease development and progression, such as cancer and neurodegeneration.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>Retrieval of Data</title>
<p>The FASTA sequence of SGK1 was taken from the UniProt (UniProt ID: O00141). A list of mutations was taken from the dbSNP (<xref ref-type="bibr" rid="B54">Sherry et&#x20;al., 2001</xref>) and Ensembl (<xref ref-type="bibr" rid="B23">Hubbard et&#x20;al., 2002</xref>) databases and an extensive literature survey. Data redundancy, including duplicate variants, was removed during preprocessing. The structural coordinates of human SGK1 were retrieved from the RCSB Protein Data Bank (PDB), using the PDB identifier 2R5T (<xref ref-type="bibr" rid="B8">Berman et&#x20;al., 2000</xref>).</p>
</sec>
<sec id="s2-2">
<title>Sequence-Based Prediction</title>
<sec id="s2-2-1">
<title>PolyPhen2</title>
<p>PolyPhen-2 is a sequence-based mutation analysis tool, and it takes the FASTA sequence as input (<xref ref-type="bibr" rid="B49">Ramensky et&#x20;al., 2002</xref>). Through conservative and physical properties, this tool calculates the potentially deleterious effects of a mutation. It incorporates multiple sequence alignments, a machine learning-based classifier, and optimized for high-throughput NGS data analysis. It provides the Position-Specific Independent Count (PSIC) score for the mutant protein and estimates the score difference with the native protein. If the PSIC score is higher than 0.09, then the amino acid substitution is considered deleterious. PolyPhen-2 is accessible through <ext-link ext-link-type="uri" xlink:href="http://genetics.bwh.harvard.edu/pph2/">http://genetics.bwh.harvard.edu/pph2/</ext-link>(<xref ref-type="bibr" rid="B1">Adzhubei et&#x20;al., 2010</xref>).</p>
</sec>
<sec id="s2-2-2">
<title>PROVEAN</title>
<p>PROVEAN estimates the impact of mutations on the protein&#x2019;s functionality based on the delta alignment score (<xref ref-type="bibr" rid="B13">Choi and Chan, 2015</xref>). For a deleterious mutation, the PROVEAN score is less than &#x2212;2.5, whereas for neutral non-synonymous mutations, scores are greater than &#x2212;2.5. The PROVEAN web server comprises three tools, PROVEAN Protein, PROVEAN Protein Batch, and PROVEAN Genome Variants. The PROVEAN Protein Batch tool also returns the result of SIFT tool and can process a large number of protein variants. The input for this function takes amino acid substitutions and supports public protein identifiers such as NCBI RefSeq, UniProt, and Ensembl. PROVEAN is accessible through <ext-link ext-link-type="uri" xlink:href="http://provean.jcvi.org/">http://provean.jcvi.org/</ext-link>.</p>
</sec>
<sec id="s2-2-3">
<title>SIFT</title>
<p>The SIFT tool considers sequence homology and physical properties of amino acid residues to determine whether the mutation is deleterious or not. It also depends on the evolutionary conservation of amino acids in protein families. The highly conserved amino acids tend to be intolerant to substitutions, and most of the less conserved ones tolerate the substitutions. (<xref ref-type="bibr" rid="B27">Kumar et&#x20;al., 2009</xref>). The SIFT score for a non-tolerable mutation is less than or equal to 0.05 (<xref ref-type="bibr" rid="B39">Ng and Henikoff, 2003</xref>; <xref ref-type="bibr" rid="B27">Kumar et&#x20;al., 2009</xref>). SIFT is accessible through <ext-link ext-link-type="uri" xlink:href="http://sift.jcvi.org/">http://sift.jcvi.org/</ext-link>.</p>
</sec>
<sec id="s2-2-4">
<title>FATHMM</title>
<p>FATHMM is another web-based application for predicting the functional impact of mutations on proteins (<xref ref-type="bibr" rid="B55">Shihab et&#x20;al., 2013</xref>). The coding variants can be analyzed for inherited diseases, such as cancer and complex diseases. FATHMM comprises two algorithms: weighted and unweighted, of which we used the unweighted algorithm for predicting the ontology of inherited diseases. The unweighted method searches conserved residues through an approach based on fundamental amino acid probabilities. The weighted method assigns pathogenicity weights that correlate with disease-causing amino acids, with sequence conservation found through searching Hidden Markov models (HMMs). FATHMM is accessible through <ext-link ext-link-type="uri" xlink:href="http://hathmm.biocompute.org.uk/">http://hathmm.biocompute.org.uk</ext-link>.</p>
</sec>
</sec>
<sec id="s2-3">
<title>Structure-Based Prediction</title>
<sec id="s2-3-1">
<title>mCSM</title>
<p>mCSM is a web-based predictor that uses a graph-based approach to predict the impact of missense mutations on protein stability (<xref ref-type="bibr" rid="B47">Pires et&#x20;al., 2014</xref>). The predictive models in mCSM are trained with the atomic distance patterns of different amino acid residues. mCSM covers a wide range of proteins for disease association of mutations. The calculated mCSM score (&#x394;&#x394;<italic>G</italic>) for a destabilizing mutation is less than 0. mCSM is accessible through <ext-link ext-link-type="uri" xlink:href="http://biosig.unimelb.edu.au/mcsm/">http://biosig.unimelb.edu.au/mcsm/</ext-link>.</p>
</sec>
<sec id="s2-3-2">
<title>SDM</title>
<p>SDM is a webserver that calculates the change in protein stability upon mutation. The protein stability change for a mutation is calculated using PDB coordinate files and environment-specific amino acid substitution tables (<xref ref-type="bibr" rid="B42">Overington et&#x20;al., 1992</xref>; <xref ref-type="bibr" rid="B44">Pandurangan et&#x20;al., 2017</xref>). If the &#x394;&#x394;<italic>G</italic> is higher than 0 for a mutation, SDM predicts it as a destabilizing mutation. SDM is accessible through <ext-link ext-link-type="uri" xlink:href="http://marid.bioc.cam.ac.uk/sdm2">http://marid.bioc.cam.ac.uk/sdm2</ext-link>.</p>
</sec>
<sec id="s2-3-3">
<title>MAESTROweb</title>
<p>MAESTROweb is a stability prediction tool that takes a multi-agent approach to estimate the free energy difference between the native and mutant protein. It accepts PDB coordinates as input and uses a machine learning-based approach to calculate the change in the Gibbs free energy value. If the MAESTRO score is less than 0 for a mutation, then it predicts that the mutation is destabilizing (<xref ref-type="bibr" rid="B28">Laimer et&#x20;al., 2015</xref>). MAESTROweb is accessible through <ext-link ext-link-type="uri" xlink:href="https://pbwww.che.sbg.ac.at/maestro/web">https://pbwww.che.sbg.ac.at/maestro/web</ext-link>.</p>
</sec>
<sec id="s2-3-4">
<title>PremPS</title>
<p>PremPS evaluates the effects of mutations on protein stability by estimating the quantitative change in unfolding Gibbs free energy (<xref ref-type="bibr" rid="B12">Chen et&#x20;al., 2020</xref>). Predictions are based on the protein structure. The PremPS tool uses a random forest (RF) regression scoring function. The tool was trained with experimental data of unfolding Gibbs free energy changes (&#x394;&#x394;G) for 5,296 mutations from 131 proteins. To improve the performance of the tool and the datasets, reverse mutations are also incorporated. For the forward mutations (&#x394;&#x394;G<sub>wt&#x2192;mut</sub>), three-dimensional structures of native proteins were taken from the PDB. The BuildModel module of FoldX is used for reverse mutations (&#x394;&#x394;G<sub>mut&#x2192;wt</sub>). The PremPS energy function is based on 10 evolutionary and structure-based features which belong to six categories. PremPS is accessible through <ext-link ext-link-type="uri" xlink:href="https://lilab.jysw.suda.edu.cn/research/PremPS/">https://lilab.jysw.suda.edu.cn/research/PremPS/</ext-link>.</p>
</sec>
</sec>
<sec id="s2-4">
<title>Disease Phenotype Prediction</title>
<sec id="s2-4-1">
<title>SNPs and GO</title>
<p>SNPs and GO is an SVM-based webserver that identifies pathogenic non-synonymous substitutions (<xref ref-type="bibr" rid="B11">Capriotti et&#x20;al., 2013</xref>). It uses gene ontology (GO) annotations to classify a missense variant into a disease-related or neutral variant. It requires amino acid sequence/SwissProt code, GO terms, and amino acid substitutions as input. An SNPs and GO score of more than 0.5 indicates a disease-causing mutation, and this tool also gives the result of PANTHER and PhD-SNP. SNPs and GO is accessible through <ext-link ext-link-type="uri" xlink:href="https://snps.biofold.org/snps-and-go/snps-and-go.html">https://snps.biofold.org/snps-and-go/snps-and-go.html</ext-link>.</p>
</sec>
<sec id="s2-4-2">
<title>PON-P2</title>
<p>PON-P2 is a machine learning-based web tool for analyzing mutations in human proteins (<xref ref-type="bibr" rid="B40">Niroula et&#x20;al., 2015</xref>). It divides the non-synonymous substitutions into pathogenic, neutral and unknown classes. It can proficiently and rapidly analyze large-scale variant datasets. For identifier submission, it takes mutation and one of Ensembl or Entrez, UniProtKB identifiers. PON-P2 uses evolutionary sequence conservation and physical and biochemical properties of a protein to calculate the potential pathogenicity of mutations. GO annotations and functional annotations are also used based on their availability. PON-P2 is accessible through <ext-link ext-link-type="uri" xlink:href="http://structure.bmc.lu.se/PON-P2/">http://structure.bmc.lu.se/PON-P2/</ext-link>.</p>
</sec>
<sec id="s2-4-3">
<title>PMut</title>
<p>PMut is one of the webservers for disease phenotype identification. PMut consists of a network-based classifier, and datasets are obtained from the manually created Swiss-Prot database. Physiochemical properties and sequence conservation are two of the main features of the tool. If the PMut score for a mutation is greater than 0.5, the mutation is considered pathogenic. The updated version also has the option to generate new predictors for specific protein families. It also has a database of the pre-estimated predictions (<xref ref-type="bibr" rid="B31">L&#xf3;pez-Ferrando et&#x20;al., 2017</xref>). PMut is accessible through <ext-link ext-link-type="uri" xlink:href="http://mmb.irbbarcelona.org/PMut">http://mmb.irbbarcelona.org/PMut</ext-link>.</p>
</sec>
</sec>
<sec id="s2-5">
<title>Analysis of Conserved Residues</title>
<p>ConSurf is a webserver for determining the degree of conservation of amino acids in a specific position using multiple sequence alignment (<xref ref-type="bibr" rid="B5">Ashkenazy et&#x20;al., 2016</xref>). The evolutionary conservation of residues is critical to understand the function and structure of a protein. The ConSurf score extends from 1 to 9, where 1 signifies the least conserved residue, and 9 is for highly conserved residues. ConSurf is accessible through <ext-link ext-link-type="uri" xlink:href="https://consurf.tau.ac.il/">https://consurf.tau.ac.il/</ext-link>.</p>
</sec>
<sec id="s2-6">
<title>Analysis of Aggregation Propensity</title>
<p>SODA is a web-based application used in studying the aggregation, disorder, helix, and strand propensity that occur due to single nucleotide polymorphisms. It is used to study various mutations, including insertion, deletion, substitution, and duplication in a protein molecule. The SODA score is based on the difference in solubility between the native and mutant protein (<xref ref-type="bibr" rid="B43">Paladin et&#x20;al., 2017</xref>). SODA is accessible through <ext-link ext-link-type="uri" xlink:href="http://protein.bio.unipd.it/soda/">http://protein.bio.unipd.it/soda/</ext-link>. The bioinformatics approach and various applications used are illustrated in <xref ref-type="fig" rid="F1">Figure&#x20;1</xref>.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Number of mutations reported in SGK1, extracted from the dbSNP database.</p>
</caption>
<graphic xlink:href="fmolb-08-780284-g001.tif"/>
</fig>
</sec>
<sec id="s2-7">
<title>MD Simulations</title>
<sec id="s2-7-1">
<title>Systems Preparation and Simulation Protocol</title>
<p>The native structure of SGK1 downloaded from the PDB was processed for deleting crystallographic water and adding missing atoms. The mutant models were prepared by utilizing the mutagenesis wizard of PyMOL (<xref ref-type="bibr" rid="B18">DeLano, 2002</xref>). All-atom MD simulation and potential energy minimization were performed on SGK1 and its mutants models using the Amber 18 software. The Amber 18 forcefield FF14SB was applied during the simulation protocol. Energy-minimized structures of all four systems (one wild-type (WT) and three mutants) were taken as the starting coordinates for the simulation. All four structures were solvated in a cubic TIP3P water model. Periodic boundary conditions were set so that the number of particles, pressure, and temperature are constant during the simulation. The simulation setups were neutralized by adding an appropriate number of counterions. The temperature at 300&#xa0;K was retained by employing the Berendsen algorithm with a coupling time of 0.2. All atoms of the protein systems were placed at a distance of 10&#xa0;&#xc5; from the edges of the cubic box. The minimized simulation setups were then equilibrated for 1,000&#xa0;ps at 300&#xa0;K via the position-restrained simulation approach for solvation. The equilibrium setups were then subjected to final MD runs for 200&#xa0;ns. The Particle mesh Ewald (PME) method was employed for long-range Coulombic interactions. The SHAKE algorithm was used to determine the bond lengths between hydrogen atoms, with a time step of 2&#xa0;fs (<xref ref-type="bibr" rid="B4">Andersen, 1983</xref>).</p>
</sec>
</sec>
<sec id="s2-7-2">
<title>Post-Dynamic Trajectory Analysis</title>
<p>The generated trajectories were analyzed using the conventional utilities of the Amber 18 suite to obtain RMSD, RMSF, <italic>R</italic>
<sub>g</sub>, SASA, intramolecular hydrogen bonding, secondary structure analysis, distance cross-correlation matrix and principal component analysis (PCA). The structural coordinates of all four systems were collected for every 1&#xa0;ps, and trajectory curves were computed via the CPPTRAJ module (<xref ref-type="bibr" rid="B50">Roe and Cheatham, 2013</xref>) of Amber 18. The number of intramolecular hydrogen bonds was defined based on a donor-hydrogen-acceptor angle &#x3e;90&#xa0;nm and a donor-acceptor distance &#x3c;3.9&#xa0;nm. VMD (<xref ref-type="bibr" rid="B24">Humphrey et&#x20;al., 1996</xref>) was used for molecular visualization of MD trajectories, and QtGrace was employed to generate plots of MD results.</p>
</sec>
<sec id="s2-7-3">
<title>Dynamics of the Cross-Correlation Matrix</title>
<p>The dynamics of the cross-correlation matrix (DCCM) were explored to determine coordinate aberrations and behaviors in C<sub>&#x3b1;</sub> atoms of SGK1 and its mutant models. The i and j cross-correlation factors of C<sub>&#x3b1;</sub> atoms can be calculated as:<disp-formula id="e1">
<mml:math id="m1">
<mml:mrow>
<mml:mo>&#xa0;</mml:mo>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mrow>
<mml:mi>i</mml:mi>
<mml:mi>j</mml:mi>
</mml:mrow>
</mml:msub>
<mml:mo>&#x3d;</mml:mo>
<mml:mfrac>
<mml:mrow>
<mml:mo>&#x3c;</mml:mo>
<mml:mtext>&#x394;ri</mml:mtext>
<mml:mo>.</mml:mo>
<mml:mtext>&#x394;rj</mml:mtext>
<mml:mo>&#x3e;</mml:mo>
</mml:mrow>
<mml:mrow>
<mml:msup>
<mml:mrow>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mo>&#x3c;</mml:mo>
<mml:mi mathvariant="italic">&#x394;</mml:mi>
<mml:msubsup>
<mml:mi>r</mml:mi>
<mml:mi>i</mml:mi>
<mml:mn>2</mml:mn>
</mml:msubsup>
<mml:mo>&#x3e;</mml:mo>
<mml:mo>&#x3c;</mml:mo>
<mml:mi mathvariant="italic">&#x394;</mml:mi>
<mml:msubsup>
<mml:mi>r</mml:mi>
<mml:mi>j</mml:mi>
<mml:mn>2</mml:mn>
</mml:msubsup>
<mml:mo>&#x3e;</mml:mo>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
<mml:mrow>
<mml:mfrac>
<mml:mn>1</mml:mn>
<mml:mn>2</mml:mn>
</mml:mfrac>
</mml:mrow>
</mml:msup>
</mml:mrow>
</mml:mfrac>
</mml:mrow>
</mml:math>
<label>(1)</label>
</disp-formula>where &#x394;r<sub>i,j</sub> is the movement of i<sup>th</sup> and j<sup>th</sup> atom average point and angle braces indicated over the complete curves. Correlated movements are denoted by C<sub>ij</sub> &#x3d; 1; however, C<sub>ij</sub> &#x3d; &#x2212;1 is supposed to be highly anti-correlated movements. The divergence of atomic movements from 1 to &#x2212;1 describes that i and j movements are correlated and anti-correlated.</p>
</sec>
<sec id="s2-7-4">
<title>PCA</title>
<p>PCA is a valuable approach to explore conformational movements in a protein (<xref ref-type="bibr" rid="B17">David and Jacobs, 2014</xref>). PCA models atomic movements of protein conformation by retaining dimensional reduction from simulated trajectories (<xref ref-type="bibr" rid="B36">Naqvi et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B3">Amir et&#x20;al., 2019b</xref>; <xref ref-type="bibr" rid="B20">Fatima et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B34">Mohammad et&#x20;al., 2019</xref>). We performed PCA through the covariance matrix C, based on the atomic coordinates and their corresponding eigenvalues (<xref ref-type="bibr" rid="B45">Papaleo et&#x20;al., 2009</xref>). The generation of positional covariance matrix C can be explained as:<disp-formula id="e2">
<mml:math id="m2">
<mml:mrow>
<mml:msub>
<mml:mi>C</mml:mi>
<mml:mi>i</mml:mi>
</mml:msub>
<mml:mo>&#x3d;</mml:mo>
<mml:mo>&#xa0;</mml:mo>
<mml:mo>&#x3c;</mml:mo>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:msub>
<mml:mi>q</mml:mi>
<mml:mi>i</mml:mi>
</mml:msub>
<mml:mo>&#x2212;</mml:mo>
<mml:mo>&#x3c;</mml:mo>
<mml:msub>
<mml:mi>q</mml:mi>
<mml:mi>i</mml:mi>
</mml:msub>
<mml:mo>&#x3e;</mml:mo>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:msub>
<mml:mi>q</mml:mi>
<mml:mi>j</mml:mi>
</mml:msub>
<mml:mo>&#x2212;</mml:mo>
<mml:mo>&#x3c;</mml:mo>
<mml:msub>
<mml:mi>q</mml:mi>
<mml:mi>j</mml:mi>
</mml:msub>
<mml:mo>&#x3e;</mml:mo>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
<mml:mo>&#x3e;</mml:mo>
<mml:mrow>
<mml:mo>(</mml:mo>
<mml:mrow>
<mml:mi>i</mml:mi>
<mml:mo>,</mml:mo>
<mml:mi>j</mml:mi>
<mml:mo>&#x3d;</mml:mo>
<mml:mn>1,2</mml:mn>
<mml:mo>,</mml:mo>
<mml:mo>&#x2026;</mml:mo>
<mml:mo>,</mml:mo>
<mml:mn>3</mml:mn>
<mml:mi>N</mml:mi>
</mml:mrow>
<mml:mo>)</mml:mo>
</mml:mrow>
</mml:mrow>
</mml:math>
<label>(2)</label>
</disp-formula>where q<sub>i</sub> and q<sub>j</sub> represent the Cartesian coordinates for the i<sup>th</sup>, j<sup>th</sup> position of the C<sub>&#x3b1;</sub> atom and N is the number of C<sup>&#x3b1;</sup>&#x20;atoms.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<p>A set of 156 reported mutations were extracted from the dbSNP and Ensembl databases. PubMed was also used to retrieve mutations through a literature search. The identification of the structural and functional impact of mutations on the SGK1 protein was performed step-by-step. All mutations were analyzed through sequence-based and structure-based methods to define deleterious mutations with high confidence. The sequence-based approach included four web-based tools, PolyPhen2, PROVEAN, SIFT and FATHMM, and the structure-based approach included mCSM, SDM, MAESTROweb, and PremPS. These eight tools separated deleterious/destabilizing mutations from stabilizing/neutral mutations, along with those of unknown significance. Further progression was made by analyzing the pathogenicity of high confidence mutations obtained through the previous two approaches. Pathogenicity of high confidence mutations was predicted through SNPs and GO, PON-P2, and PMut web servers. The distribution of different types of mutations in the SGK1 is depicted in <xref ref-type="fig" rid="F2">Figure&#x20;2</xref>.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Overview of representation of the computational approach used to identify the deleterious mutations in SGK1.</p>
</caption>
<graphic xlink:href="fmolb-08-780284-g002.tif"/>
</fig>
<sec id="s3-1">
<title>Identification of Deleterious Mutations</title>
<p>The analysis includes multiple tools to generate more accurate results by eliminating false Predictions. PolyPhen2, PROVEAN, SIFT, and FATHMM were used as part of the sequence-based approach. The SIFT web tool is based on the physical properties of a protein and separates the mutations into tolerated and intolerant substitutions. A higher tolerance score indicates a lower impact of a mutation on the protein function and vice versa (<xref ref-type="bibr" rid="B39">Ng and Henikoff, 2003</xref>).</p>
<p>PolyPhen-2 is another tool based on an iterative greedy algorithm and classifies the mutations into three categories: probably damaging (score &#x3e;0.96), possibly damaging (score &#x3e;0.2 and &#x3c;0.96), and benign (score &#x3c;0.2). To improve accuracy, two other tools PROVEAN and FATHMM tools were&#x20;used.</p>
<p>The substitutions which destabilize the structure of a protein are generally involved in various diseases (<xref ref-type="bibr" rid="B37">Ng and Henikoff, 2001</xref>; <xref ref-type="bibr" rid="B46">Petukh et&#x20;al., 2015</xref>). The change in free energy during the unfolding of a kinetically stable protein is described by the &#x394;&#x394;<italic>G</italic> value. Sometimes a single amino acid substitution in proteins differentiates the free energy landscape between the mutant and WT protein. This variance in the free energy landscape is why a mutation affects the stability of a protein. Thermodynamically, the energy difference between a folded and unfolded protein can be considered as &#x394;<italic>G</italic>&#x20;&#x3d; Gu-Gf. The change of protein stability (&#x394;&#x394;<italic>G</italic>) and free energy landscape between mutant (Gm) and WT (Gw) is considered as &#x394;&#x394;<italic>G</italic>&#x20;&#x3d; Gm-Gw (<xref ref-type="bibr" rid="B10">Bowker-Kinley et&#x20;al., 1998</xref>). A more positive &#x394;&#x394;<italic>G</italic> shows a destabilizing mutation, whereas a negative &#x394;&#x394;<italic>G</italic> indicates a more stabilizing mutation (<xref ref-type="bibr" rid="B48">Quan et&#x20;al., 2016</xref>). We used various sequence-based predictors, i.e.,&#x20;PolyPhen2, PROVEAN, SIFT, and FATHMM, predicted that out of the 156 mutations, 92 (58.97%), 106 (67.94%), 81 (51.92%), and 38 (24.34%) were deleterious, respectively (<xref ref-type="fig" rid="F3">Figure&#x20;3A</xref>), (<xref ref-type="sec" rid="s11">Supplementary Table&#x20;S1</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Deleterious and neutral mutations in SGK1 predicted by <bold>(A)</bold> sequence-based and <bold>(B)</bold> structure-based tools.</p>
</caption>
<graphic xlink:href="fmolb-08-780284-g003.tif"/>
</fig>
<p>Structure-based predictors, i.e.,&#x20;mCSM, SDM, MAESTROweb, and PremPS, combine machine learning-based and biophysics-based approaches to determine the stability of mutants, calculating their free energy. This analysis showed that 139 (89.1%), 85 (54.48%), 118 (75.64%), and 144 (92.3%) mutations were destabilizing (<xref ref-type="fig" rid="F3">Figure&#x20;3B</xref>; <xref ref-type="sec" rid="s11">Supplementary Table S2</xref>). Mutations predicted to be deleterious by at least three different sequence-based and three different structure-based tools were selected to increase confidence levels. Here, 134 mutations were selected and then analyzed for their pathogenicity.</p>
</sec>
<sec id="s3-2">
<title>Identification of Pathogenic Variations</title>
<p>The selected mutations were predicted for their pathogenicity using the SNPs and GO, PON-P2, and PMut. From the 134 mutations, SNPs and GO, PON-P2, and PMut predicted 56, 40, and 49 mutations as pathogenic, respectively, (<xref ref-type="fig" rid="F4">Figure&#x20;4</xref>). From these, only 20 mutations (P87R, K127M, R147W, L172W, G181V, Y186C, R198P, L230P, T256A, T256D, T256E, V278M, P296R, Y298A, I320N, D335V, R339W, G341A, P371R, and P374L) were predicted as pathogenic from all the prediction tools (<xref ref-type="sec" rid="s11">Supplementary Table&#x20;S3</xref>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Pathogenic mutations in the SGK1 protein, identified using SNPs and GO, PON-P2, and PMut.</p>
</caption>
<graphic xlink:href="fmolb-08-780284-g004.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>Analysis of Evolutionarily Conserved Residues</title>
<p>The overall integrity of a protein structure mainly depends on the conserved residues (<xref ref-type="bibr" rid="B53">Shakhnovich et&#x20;al., 1996</xref>). Analysis of amino acid residue conservation in a protein structure is used to understand its importance and localized evolution. The propensity of an amino acid residue to mutate is subject to the degree of conservation (<xref ref-type="bibr" rid="B5">Ashkenazy et&#x20;al., 2016</xref>). The SGK1 structure was analyzed to obtain the degree of conservation of each residue in the protein. The ConSurf analysis shows that the amino acids forming the central region of the SGK1 protein are highly conserved than those at the N- and C-termini (<xref ref-type="fig" rid="F5">Figure&#x20;5</xref>). This signifies that any substitution in the central region of SGK1 will have more tendency to instability and thus its dysfunction in many diseases.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Sequence Conservation analysis of the SGK1 protein using ConSurf web server.</p>
</caption>
<graphic xlink:href="fmolb-08-780284-g005.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>Analysis of Aggregation Propensity</title>
<p>The solubility of a protein highly impacts its functionality (<xref ref-type="bibr" rid="B7">Balch et&#x20;al., 2008</xref>; <xref ref-type="bibr" rid="B16">Ciryam et&#x20;al., 2013</xref>). Diseases like Alzheimer&#x2019;s (<xref ref-type="bibr" rid="B57">Thal et&#x20;al., 2015</xref>), amyloidosis (<xref ref-type="bibr" rid="B25">Knowles et&#x20;al., 2014</xref>), and Parkinson&#x2019;s diseases (<xref ref-type="bibr" rid="B25">Knowles et&#x20;al., 2014</xref>) are associated with protein aggregation. SODA predicts that out of the 20, 8 mutations decrease the solubility of the protein, whereas the other 12 increase the solubility of the SGK1 protein (<xref ref-type="table" rid="T1">Table&#x20;1</xref>). These mutants have a high tendency to get aggregate, thus their involvement in protein aggregation-associated disease progression. Finally, based on the functional importance and location of the mutations, three amino acid substitutions, i.e.,&#x20;K127M, T256A, and Y298A, were selected and studied in detail (<xref ref-type="bibr" rid="B26">Kobayashi and Cohen, 1999</xref>; <xref ref-type="bibr" rid="B56">Snyder et&#x20;al., 2002</xref>; <xref ref-type="bibr" rid="B9">Boehmer et&#x20;al., 2003</xref>).</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Aggregation propensity of SGK1 mutant proteins predicted through SODA.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Sequence</th>
<th align="center">Helix</th>
<th align="center">Strand</th>
<th align="center">Aggregation</th>
<th align="center">Disorder</th>
<th align="center">SODA</th>
<th align="center">Remark</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">Wild type</td>
<td align="char" char=".">0.430</td>
<td align="char" char=".">0.144</td>
<td align="char" char=".">&#x2013;4.596</td>
<td align="char" char=".">0.084</td>
<td align="center">N/A</td>
<td align="left">N/A</td>
</tr>
<tr>
<td align="left">P87R</td>
<td align="char" char=".">&#x2013;0.114</td>
<td align="char" char=".">0.261</td>
<td align="char" char=".">&#x2013;1.542</td>
<td align="char" char=".">0.311</td>
<td align="char" char=".">&#x2013;0.152</td>
<td align="left">Less soluble</td>
</tr>
<tr>
<td align="left">K127M</td>
<td align="char" char=".">&#x2013;0.218</td>
<td align="char" char=".">0.174</td>
<td align="char" char=".">&#x2013;33.564</td>
<td align="char" char=".">&#x2013;0.131</td>
<td align="char" char=".">&#x2013;33.926</td>
<td align="left">Less soluble</td>
</tr>
<tr>
<td align="left">R147W</td>
<td align="char" char=".">&#x2013;3.366</td>
<td align="char" char=".">2.907</td>
<td align="char" char=".">&#x2013;7.635</td>
<td align="char" char=".">&#x2013;0.009</td>
<td align="char" char=".">&#x2013;8.560</td>
<td align="left">Less soluble</td>
</tr>
<tr>
<td align="left">L172W</td>
<td align="char" char=".">5.718</td>
<td align="char" char=".">&#x2013;4.082</td>
<td align="char" char=".">&#x2013;77.368</td>
<td align="char" char=".">&#x2013;0.05</td>
<td align="char" char=".">&#x2013;74.497</td>
<td align="left">Less soluble</td>
</tr>
<tr>
<td align="left">G181V</td>
<td align="char" char=".">&#x2013;2.478</td>
<td align="char" char=".">1.961</td>
<td align="char" char=".">&#x2013;1.198</td>
<td align="char" char=".">&#x2013;0.002</td>
<td align="char" char=".">&#x2013;2.202</td>
<td align="left">Less soluble</td>
</tr>
<tr>
<td align="left">Y186C</td>
<td align="char" char=".">2.108</td>
<td align="char" char=".">&#x2013;1.510</td>
<td align="char" char=".">&#x2013;32.643</td>
<td align="char" char=".">0.009</td>
<td align="char" char=".">&#x2013;31.684</td>
<td align="left">Less soluble</td>
</tr>
<tr>
<td align="left">R198P</td>
<td align="char" char=".">0.048</td>
<td align="char" char=".">-0.834</td>
<td align="char" char=".">7.485</td>
<td align="char" char=".">&#x2013;0.044</td>
<td align="center">6.452</td>
<td align="left">More soluble</td>
</tr>
<tr>
<td align="left">L230P</td>
<td align="char" char=".">&#x2013;0.328</td>
<td align="char" char=".">-0.405</td>
<td align="char" char=".">4.512</td>
<td align="char" char=".">0.013</td>
<td align="center">2.851</td>
<td align="left">More soluble</td>
</tr>
<tr>
<td align="left">T256A</td>
<td align="char" char=".">1.313</td>
<td align="char" char=".">&#x2013;0.680</td>
<td align="char" char=".">0.973</td>
<td align="char" char=".">&#x2013;0.024</td>
<td align="center">1.889</td>
<td align="left">More soluble</td>
</tr>
<tr>
<td align="left">T256D</td>
<td align="char" char=".">&#x2013;0.074</td>
<td align="char" char=".">&#x2013;0.231</td>
<td align="char" char=".">3.709</td>
<td align="char" char=".">&#x2013;0.028</td>
<td align="center">3.356</td>
<td align="left">More soluble</td>
</tr>
<tr>
<td align="left">T256E</td>
<td align="char" char=".">0.374</td>
<td align="char" char=".">-0.186</td>
<td align="char" char=".">0.886</td>
<td align="char" char=".">-0.013</td>
<td align="center">1.548</td>
<td align="left">More soluble</td>
</tr>
<tr>
<td align="left">V278M</td>
<td align="char" char=".">0.318</td>
<td align="char" char=".">-0.243</td>
<td align="char" char=".">1.443</td>
<td align="char" char=".">&#x2013;0.014</td>
<td align="center">1.193</td>
<td align="left">More soluble</td>
</tr>
<tr>
<td align="left">P296R</td>
<td align="char" char=".">0.024</td>
<td align="char" char=".">&#x2013;0.021</td>
<td align="char" char=".">4.544</td>
<td align="char" char=".">&#x2013;0.136</td>
<td align="center">4.649</td>
<td align="left">More soluble</td>
</tr>
<tr>
<td align="left">Y298A</td>
<td align="char" char=".">&#x2013;0.400</td>
<td align="char" char=".">0.216</td>
<td align="char" char=".">2.101</td>
<td align="char" char=".">0.004</td>
<td align="center">1.973</td>
<td align="left">More soluble</td>
</tr>
<tr>
<td align="left">I320N</td>
<td align="char" char=".">&#x2013;0.040</td>
<td align="char" char=".">-0.258</td>
<td align="char" char=".">1.305</td>
<td align="char" char=".">0.022</td>
<td align="center">0.752</td>
<td align="left">More soluble</td>
</tr>
<tr>
<td align="left">D335V</td>
<td align="char" char=".">&#x2013;0.252</td>
<td align="char" char=".">0.123</td>
<td align="char" char=".">&#x2013;19.314</td>
<td align="char" char=".">&#x2013;0.283</td>
<td align="char" char=".">&#x2013;20.671</td>
<td align="left">Less soluble</td>
</tr>
<tr>
<td align="left">R339W</td>
<td align="char" char=".">0.005</td>
<td align="char" char=".">0.051</td>
<td align="char" char=".">&#x2013;3.193</td>
<td align="char" char=".">&#x2013;0.342</td>
<td align="char" char=".">&#x2013;4.114</td>
<td align="left">Less soluble</td>
</tr>
<tr>
<td align="left">G341A</td>
<td align="char" char=".">1.228</td>
<td align="char" char=".">&#x2013;0.581</td>
<td align="char" char=".">0.896</td>
<td align="char" char=".">0.005</td>
<td align="center">1.470</td>
<td align="left">More soluble</td>
</tr>
<tr>
<td align="left">P371R</td>
<td align="char" char=".">0.912</td>
<td align="char" char=".">&#x2013;0.122</td>
<td align="char" char=".">8.732</td>
<td align="char" char=".">0.022</td>
<td align="center">10.473</td>
<td align="left">More soluble</td>
</tr>
<tr>
<td align="left">P374L</td>
<td align="char" char=".">0.894</td>
<td align="char" char=".">&#x2013;0.526</td>
<td align="char" char=".">7.055</td>
<td align="char" char=".">0.067</td>
<td align="center">8.005</td>
<td align="left">More soluble</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s3-5">
<title>MD Simulations</title>
<sec id="s3-5-1">
<title>Post-Dynamics Trajectory Analysis</title>
<p>MD simulations provide the platform for the comprehensive analysis of the effect of mutations on protein structure. Based on this, SGK1 mutations, i.e.,&#x20;K127M, T256A, and Y298A, were investigated using 200&#xa0;ns simulated trajectories. Global protein stability and dynamics upon mutation were assessed through the time evolution of RMSD values. We computed the RMSDs for all four systems (SGK1 WT and its mutants) from the average simulated structure and plotted them for analysis (<xref ref-type="fig" rid="F6">Figure&#x20;6A</xref>). All four systems achieved convergence after 60&#xa0;ns of simulation. We observed a significant structural deviation in the T256A mutant compared with K127M, Y298A, and native SGK1. The RMSD values for T256A had a deviation of &#x223c;0.2&#xa0;nm from native SGK1 distributed throughout the simulation. The structures of Y298A and K127M had lower RMSD values compared with native SGK1. Although the mutants exhibited little deviation except T256A in the RMSD from the native structure. However, no substantial differences were observed in the structural snaps except the loop and N-terminal helices of superimposed SGK1-WT, K127M, T256A, and Y298A at every 50&#xa0;ns during the simulation (<xref ref-type="sec" rid="s11">Supplementary Figure S1</xref>). We plotted the dynamics of RMSD as the probability distribution function (PDF), which also illustrated a significant shift of &#x223c;5&#xa0;&#xc5; in T256A values with higher probability (<xref ref-type="sec" rid="s11">Supplementary Figure&#x20;S2A</xref>).</p>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Structural dynamics of SGK1 WT (red), K127M (black), T256A (green), and Y298A (blue) mutants <bold>(A)</bold> RMSD, <bold>(B)</bold> RMSF, <bold>(C)</bold> Rg, and <bold>(D)</bold> SASA values across C&#x3b1; backbone in &#xc5; of WT, K127M, T256A, and Y298A mutants calculated after 200&#xa0;ns of MD trajectories.</p>
</caption>
<graphic xlink:href="fmolb-08-780284-g006.tif"/>
</fig>
<p>To explore the structural flexibility of active SGK1 and its mutants, we computed the RMSFs of each residue in the protein&#x2019;s backbone (<xref ref-type="fig" rid="F6">Figure&#x20;6B</xref>). SGK1 showed random fluctuations ranging from the N to the C termini, where the T256A mutant showed the highest fluctuations in most residues. Almost all residues in all systems exhibited a similar pattern of fluctuation; however, major changes were observed in the range of Q40-E120 amino acid residues. The mutant systems showed higher fluctuation compared to the native structure. In the T256A mutant, notable changes in fluctuation were observed for residues &#x223c;50&#x2013;80, whereas mutant K127M revealed several significant higher fluctuations for residues &#x223c;10&#x2013;30, &#x223c;60&#x2013;70, &#x223c;110&#x2013;120, and &#x223c;230&#x2013;240. The major peaks in the RMSF values of T256A were direct associated with the RMSD trend, where it majorly deviated from its initial position.</p>
<p>
<italic>R</italic>g analysis exposes the structural compactness, stability, and folding mechanism of a protein structure (<xref ref-type="bibr" rid="B30">Lobanov et&#x20;al., 2008</xref>). The folding mechanism and conformational behavior of the SGK1 structure and its mutants were studied by examining the time evolution of the <italic>R</italic>g values. We computed the <italic>R</italic>g values of native SGK1, K127M, T256A, and Y298A systems from the generated MD trajectories of 200&#xa0;ns (<xref ref-type="fig" rid="F6">Figure&#x20;6C</xref>). The <italic>R</italic>g of T256A and K127M exhibited the most deviation compared to WT and Y298A, especially after 30&#xa0;ns. The Y298A structure also seems to be unfolded, showing several random fluctuations in its <italic>Rg</italic> values. The K127M mutant shows lower <italic>Rg</italic> thus higher compactness overall during the simulations. The PDF analysis also suggested a higher increase in the average <italic>R</italic>g values of T256A than WT SGK1, K127M, and Y298A suggested looseness of its conformational packing (<xref ref-type="sec" rid="s11">Supplementary Figure&#x20;S2B</xref>).</p>
<p>The SASA of a protein molecule is the surface area in contact with its surrounding solvent. The solvation power has a crucial role in maintaining the overall structure and folding of a protein. An inappropriate folded/unstable protein will not perform the function it supposes to be. So, it becomes crucial to study the folding behavior of the proteins upon mutations while exploring their SASA and packing density. The solvation power of a protein can be evaluated by explicit solvent models implemented in conventional MD simulation approaches. The time evolution of the SASA of native SGK1 and its mutant&#x2019;s structure was computed and plotted (<xref ref-type="fig" rid="F6">Figure&#x20;6D</xref>). This shows that T256A had higher SASA values than other systems, whereas K127M displayed a somewhat lower SASA than the native SGK1, agreeing with the <italic>Rg</italic> results. A clear shift in the distribution of the T256A SASA values in the PDF plot suggested a significant exposer of the buried residues of the protein thus its conformational shift (<xref ref-type="sec" rid="s11">Supplementary Figure&#x20;S2C</xref>).</p>
</sec>
<sec id="s3-5-2">
<title>Intramolecular Hydrogen Bond Analysis</title>
<p>Hydrogen bonds (H-bonds) are the most essential intramolecular interactions within a protein molecule (<xref ref-type="bibr" rid="B35">Myers and Pace, 1996</xref>). Since these interactions make major contributions to maintaining the stability of the protein structure, exploring the function of H-bonds offers crucial information about protein stability. Thus, we studied the time evolution of the number of intramolecular H-bonds in native and mutant SGK1 to understand structural stability during the simulation (<xref ref-type="fig" rid="F7">Figure&#x20;7</xref>). The hydrogen bonding showed a little decrement in the number of intramolecular H-bonds in mutants throughout the simulation, especially in T256A.</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>Intramolecular hydrogen bond analysis in SGK1 WT (red), K127M (black), T256A (green), and Y298A (blue).</p>
</caption>
<graphic xlink:href="fmolb-08-780284-g007.tif"/>
</fig>
</sec>
<sec id="s3-5-3">
<title>Secondary Structure Analysis</title>
<p>The dynamics of secondary structure components in SGK1 and its mutants were evaluated from the MD trajectories of 200&#xa0;ns. This further improves the understanding of the impact of mutations on the secondary structure of SGK1 during the simulations. The secondary structure components in SGK1, i.e.,&#x20;&#x3b1;-helix, &#x3b2;-sheets and turns, were split into specific residues for each time step. It was observed that the average number of residues that participated in the formation of secondary structure was somewhat decreased in T256A (<xref ref-type="fig" rid="F8">Figure&#x20;8</xref>). This reduction was related to increases in the formation of turns and a slight decrease in &#x3b1;-helices and &#x3b2;-sheets (<xref ref-type="table" rid="T2">Table&#x20;2</xref>).</p>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>Secondary structural contents of SGK1 WT; T256A; K127M; and Y298A mutants.</p>
</caption>
<graphic xlink:href="fmolb-08-780284-g008.tif"/>
</fig>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>Percentage of amino acid residues participating in the secondary structure of SGK1-WT, SGK1-T256A, SGK1-K127M, and SGK1-Y298A.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="left">Protein system</th>
<th align="center">&#x3b1;-helix</th>
<th align="center">&#x3b2;-sheets</th>
<th align="center">3<sub>10</sub>-helix</th>
<th align="center">Turn</th>
<th align="center">Bend</th>
<th align="center">Other</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">&#xa0;SGK1-WT</td>
<td align="char" char=".">25</td>
<td align="char" char=".">24</td>
<td align="char" char=".">4</td>
<td align="char" char=".">10</td>
<td align="char" char=".">13</td>
<td align="char" char=".">21</td>
</tr>
<tr>
<td align="left">SGK1-T256A</td>
<td align="char" char=".">22</td>
<td align="char" char=".">21</td>
<td align="char" char=".">6</td>
<td align="char" char=".">11</td>
<td align="char" char=".">7</td>
<td align="char" char=".">23</td>
</tr>
<tr>
<td align="left">SGK1-K127M</td>
<td align="char" char=".">28</td>
<td align="char" char=".">25</td>
<td align="char" char=".">7</td>
<td align="char" char=".">16</td>
<td align="char" char=".">11</td>
<td align="char" char=".">24</td>
</tr>
<tr>
<td align="left">SGK1-Y298A</td>
<td align="char" char=".">27</td>
<td align="char" char=".">26</td>
<td align="char" char=".">4</td>
<td align="char" char=".">12</td>
<td align="char" char=".">9</td>
<td align="char" char=".">20</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
</sec>
<sec id="s3-6">
<title>Distance Cross-Correlation Matrix</title>
<p>Distance cross-correlation matrices were generated and evaluated for the native SGK1 and K127M, T256A, and Y298A mutants to determine correlated and anti-correlated movements in the protein&#x2019;s structure (<xref ref-type="fig" rid="F9">Figure&#x20;9</xref>). It was observed that SGK1 scattered into some populations through positive and negative correlations concerning residual movements. The movements in native SGK1 were quite equal in both positive and negative phases. In contrast, substantial variation was observed for mutants, especially in K127M and T256A, with more negative correlations. However, there was a slight positive correlation was observed in the K127M, majorly between 50 and 100 amino acid residues.</p>
<fig id="F9" position="float">
<label>FIGURE 9</label>
<caption>
<p>Dynamics cross-correlation matrices of SGK1-WT, K127M, T256A, and Y298A generated from 200&#xa0;ns of MD trajectories.</p>
</caption>
<graphic xlink:href="fmolb-08-780284-g009.tif"/>
</fig>
</sec>
<sec id="s3-7">
<title>PCA</title>
<p>The structural dynamics of a protein&#x2019;s structure can be examined through its phase space performance. It has been exploited to observe the collective motions and conformational sampling of the proteins. PCA was performed using the essential dynamics approach to explore the conformational sampling and atomic motions of SGK1 and its mutants. PCA plots were constructed with PCs based on the first two eigenvectors (EVs) (<xref ref-type="fig" rid="F10">Figure&#x20;10</xref>). The two-dimensional scatter plot reveals the conformational activities employed by SGK1 and its mutants (<xref ref-type="fig" rid="F10">Figure&#x20;10A</xref>). At the same time, the PC1 motions in SGK1 and its mutants were assessed (<xref ref-type="fig" rid="F10">Figure&#x20;10B</xref>). The 2D scatter plot (<xref ref-type="fig" rid="F10">Figure&#x20;10A</xref>) indicates a prominent shift in the collective movements of mutant systems.</p>
<fig id="F10" position="float">
<label>FIGURE 10</label>
<caption>
<p>Conformational projection of SGK1 and its mutants. <bold>(A)</bold> Principal component analysis (PCA) of SGK1 WT (red), K127M (black), T256A (green), and Y298A (blue) mutants calculated after 200&#xa0;ns of MD trajectories. <bold>(B)</bold> PC1 collective motions for the obtained predominant eigenvectors using PCA over the 200&#xa0;ns MD trajectories for SGK1 WT, K127M, T256A, and Y298A mutants of SGK1.</p>
</caption>
<graphic xlink:href="fmolb-08-780284-g010.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>This study employs a systematic computational approach based on various biophysical algorithms to study the impact of mutations on SGK1 structure and function for understanding their association with multiple diseases, such as cancer and neurodegeneration. Sequence and structure-based analyses suggested that 134 mutations were deleterious out of a total of 156 mutations present in SGK1. Here, 20 mutations were found to be pathogenic, predicted through the pathogenicity study. Further, aggregation tendency analysis showed that only 8 mutations in SGK1 were less soluble and tended to form aggregates. The ConSurf analysis showed that the amino acids forming the middle segment of the SGK1 protein are highly conserved than those at the N- and C-termini. Finally, based on the functional importance (<xref ref-type="bibr" rid="B26">Kobayashi and Cohen, 1999</xref>; <xref ref-type="bibr" rid="B56">Snyder et&#x20;al., 2002</xref>; <xref ref-type="bibr" rid="B9">Boehmer et&#x20;al., 2003</xref>) and location of the mutations, three amino acid substitutions, i.e.,&#x20;K127M, T256A, and Y298A, were selected and studied in detail. A detailed analysis of these mutations was performed, with the help of MD simulation studies for 200 ns, followed by DCCM and PCA studies.</p>
<p>In MD simulations, the RMSD of T256A reflects a stability change in the structure and indicates the deleterious impact of the mutation on SGK1. A major deviation was also observed in the K127M mutant intramolecularly at the 50&#xa0;ns time step, suggesting a significant impact of the mutation on the ATP binding site. The RMSF analysis suggested that the residual fluctuations in all the mutants deviated from the native structure. These deviations in RMSFs reflect the impact of deleterious mutations on the SGK1 structure. While evaluating the compactness of SGK1 and its mutants, the <italic>R</italic>g showed reduced stability of all three mutants during the course of simulations, suggesting structural lethality in SGK1 resulting from the induced mutations. The notable differences in SASA values of the mutants revealed that relocation of amino acid residues from accessible areas to buried regions, or vice versa, may take place and can cause significant changes to protein stability. Together, these explanations reveal that alterations in the SGK1 structure are associated with the induced mutations.</p>
<p>The intramolecular hydrogen bond analysis showed that the number of H-bonds in the mutants fluctuated compared with the stable number of H-bonds in the native SGK1. This fluctuation in H-bonds in the mutants indicates the impact of induced mutations and their capability to obliterate H-bond formation in SGK1. Secondary structure analysis showed that &#x3b1;-helices and &#x3b2;-sheets were increased in SGK1 after K127M and Y298A mutations, while a slight decrease was detected in the percentage of bends. This residual reduction in &#x3b1;-helices and &#x3b2;-strands of T256A suggests a loss in structure, thus its dysfunction. In DCCM, the correlated and anti-correlated movements in native SGK1 and Y298A appear to be more similar compared to K127M and T256A, suggesting SGK1 altered activity in K127M and T256A mutants. PCA indicated that K127M has highly positive correlated fluctuations on both EVs, signifying its altered movements. Whereas with T256A and Y298A mutants, noticeable positively correlated progress was only observed on EV1. Overall, the PCA suggests that K127, T256A, and Y298A mutations cause large instabilities in the SGK1 structural movements during the simulation.</p>
</sec>
<sec sec-type="conclusion" id="s5">
<title>Conclusion</title>
<p>Single amino acid substitutions are among the most frequent genetic variations associated with numerous diseases, including cancer and neurodegeneration. Extensive analysis of amino acid substitutions helps to understand disease mechanisms and find effective treatments. Here, we have extensively analyzed the effects of known mutations in SGK1 protein on its structure and function. Sequence and structure-based analyses suggest that out of 156 mutations present SGK1, 134 mutations were deleterious and destabilizing. Here, 20 mutations were found to be pathogenic, predicted through the pathogenicity study. Further, aggregation tendency analysis showed that only 8 mutations in SGK1 were less soluble and tended to form aggregates, resulting in protein dysfunction, thus might involve in aggregation-associated disease progression. Finally, based on the functional importance and location of the mutations, three amino acid substitutions, i.e.,&#x20;K127M, T256A, and Y298A, were selected and studied in detail. A detailed analysis of these mutations was performed, with the help of MD simulation studies for 200&#xa0;ns, followed by PCA and DCCM studies. MD simulations result suggested that the pathogenic impact of these mutations may arise due to structural modifications in SGK1. MD simulation analyses, including RMSD, RMSF, Rg, SASA, DCCM, and PCA, indicated that SGK1 undergoes substantial conformational changes due to mutations, especially in the case of K127 and T256A. This study provides a comprehensive understanding of the mutations in SGK1 and their possible consequences for disease progression.</p>
</sec>
</body>
<back>
<sec id="s6">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s11">Supplementary Material</xref>, further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec id="s7">
<title>Author Contributions</title>
<p>All authors have read and agreed to publish the current version of the article. Conceptualization, MA, TM, and MIH; methodology, AC, SK, TM, and SS; software, TM, SN, SK, and AH; validation, AE, SS, PH, VC, WL, and MIH; formal analysis, AE, SS, and SK; investigation, MA, SK, and TM; resources; data curation MA, SS, and MIH; writing&#x2014;original draft preparation, AH, MA, SK. SN. WL, ME, PH, VC, and MIH; writing&#x2014;review and editing, TM, and MIH; visualization, SS, and AE; supervision, AE and MIH; project administration, SS, and MIH; funding acquisition, MIH and&#x20;MA.</p>
</sec>
<sec id="s8">
<title>Funding</title>
<p>Indian Council of Medical Research (Government of India) for the financial support (Grant No. ECD/Adhoc/2/2021-22).</p>
</sec>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ack>
<p>AME extend his appreciation to Deanship of Scientific Research at Jouf University for funding his work thorugh Research Grant Number (DSR-2021-01-0371). SK acknowledges NRF and AMR-H3D at UCT for financial assistance and thanks to the CHPC, South Africa, for providing technical support. PH is funded by a Fellowship and grants from the National Health and Medical Research Council (NHMRC) of Australia (1175134) and by UTS. MIH Authors thanks the Department of Science and Technology, Government of India for the FIST support (FIST program No. SR/FST/LSII/2020/782). SS is supported by grants from Clifford Craig Foundation Launceston General Hospital and Rebecca L Cooper Medical Research Foundation.</p>
</ack>
<sec id="s11">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmolb.2021.780284/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fmolb.2021.780284/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.docx" id="SM1" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adzhubei</surname>
<given-names>I. A.</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Peshkin</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ramensky</surname>
<given-names>V. E.</given-names>
</name>
<name>
<surname>Gerasimova</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bork</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>A Method and Server for Predicting Damaging Missense Mutations</article-title>. <source>Nat. Methods</source> <volume>7</volume>, <fpage>248</fpage>&#x2013;<lpage>249</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth0410-248</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amir</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Mohammad</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Dohare</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Hussain</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rehman</surname>
<given-names>M. T.</given-names>
</name>
<etal/>
</person-group> (<year>2019a</year>). <article-title>Investigation of Deleterious Effects of nsSNPs in the POT1 Gene: a Structural Genomics&#x2010;based Approach to Understand the Mechanism of Cancer Development</article-title>. <source>J.&#x20;Cel Biochem</source> <volume>120</volume>, <fpage>10281</fpage>&#x2013;<lpage>10294</lpage>. <pub-id pub-id-type="doi">10.1002/jcb.28312</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amir</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Mohammad</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>AlAjmi</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Rehman</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Hussain</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2019b</year>). <article-title>Structural Analysis and Conformational Dynamics of STN1 Gene Mutations Involved in Coat Plus Syndrome</article-title>. <source>Front. Mol. Biosci.</source> <volume>6</volume>, <fpage>41</fpage>. <pub-id pub-id-type="doi">10.3389/fmolb.2019.00041</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andersen</surname>
<given-names>H. C.</given-names>
</name>
</person-group> (<year>1983</year>). <article-title>Rattle: A &#x201c;Velocity&#x201d; Version of the Shake Algorithm for Molecular Dynamics Calculations</article-title>. <source>J.&#x20;Comput. Phys.</source> <volume>52</volume>, <fpage>24</fpage>&#x2013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/0021-9991(83)90014-1</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ashkenazy</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Abadi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Martz</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Chay</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Mayrose</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Pupko</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>ConSurf 2016: an Improved Methodology to Estimate and Visualize Evolutionary Conservation in Macromolecules</article-title>. <source>Nucleic Acids Res.</source> <volume>44</volume>, <fpage>W344</fpage>&#x2013;<lpage>W350</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkw408</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baak</surname>
<given-names>J.&#x20;P. A.</given-names>
</name>
<name>
<surname>Path</surname>
<given-names>F. R. C.</given-names>
</name>
<name>
<surname>Hermsen</surname>
<given-names>M. A. J.&#x20;A.</given-names>
</name>
<name>
<surname>Meijer</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Janssen</surname>
<given-names>E. A. M.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Genomics and Proteomics in Cancer</article-title>. <source>Eur. J.&#x20;Cancer</source> <volume>39</volume>, <fpage>1199</fpage>&#x2013;<lpage>1215</lpage>. <pub-id pub-id-type="doi">10.1016/s0959-8049(03)00265-x</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Balch</surname>
<given-names>W. E.</given-names>
</name>
<name>
<surname>Morimoto</surname>
<given-names>R. I.</given-names>
</name>
<name>
<surname>Dillin</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kelly</surname>
<given-names>J.&#x20;W.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Adapting Proteostasis for Disease Intervention</article-title>. <source>Science</source> <volume>319</volume>, <fpage>916</fpage>&#x2013;<lpage>919</lpage>. <pub-id pub-id-type="doi">10.1126/science.1141448</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berman</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>Westbrook</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Gilliland</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bhat</surname>
<given-names>T. N.</given-names>
</name>
<name>
<surname>Weissig</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2000</year>). <article-title>The Protein Data Bank</article-title>. <source>Nucleic Acids Res.</source> <volume>28</volume>, <fpage>235</fpage>&#x2013;<lpage>242</lpage>. <pub-id pub-id-type="doi">10.1093/nar/28.1.235</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boehmer</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Henke</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Schniepp</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Palmada</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Rothstein</surname>
<given-names>J.&#x20;D.</given-names>
</name>
<name>
<surname>Br&#xf6;er</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>Regulation of the Glutamate Transporter EAAT1 by the Ubiquitin Ligase Nedd4-2 and the Serum and Glucocorticoid-Inducible Kinase Isoforms SGK1/3 and Protein Kinase B</article-title>. <source>J.&#x20;Neurochem.</source> <volume>86</volume>, <fpage>1181</fpage>&#x2013;<lpage>1188</lpage>. <pub-id pub-id-type="doi">10.1046/j.1471-4159.2003.01937.x</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bowker-Kinley</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>W. I.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Popov</surname>
<given-names>K. M.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Evidence for Existence of Tissue-specific Regulation of the Mammalian Pyruvate Dehydrogenase Complex</article-title>. <source>Biochem. J.</source> <volume>329</volume> (<issue>Pt 1</issue>), <fpage>191</fpage>&#x2013;<lpage>196</lpage>. <pub-id pub-id-type="doi">10.1042/bj3290191</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Capriotti</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Calabrese</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Fariselli</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Martelli</surname>
<given-names>P. L.</given-names>
</name>
<name>
<surname>Altman</surname>
<given-names>R. B.</given-names>
</name>
<name>
<surname>Casadio</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>WS-SNPs&#x26;GO: a Web Server for Predicting the Deleterious Effect of Human Protein Variants Using Functional Annotation</article-title>. <source>BMC genomics</source> <volume>14</volume> (<issue>Suppl. 3</issue>), <fpage>S6</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2164-14-S3-S6</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>PremPS: Predicting the Impact of Missense Mutations on Protein Stability</article-title>. <source>Plos Comput. Biol.</source> <volume>16</volume>, <fpage>e1008543</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pcbi.1008543</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>A. P.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>PROVEAN Web Server: a Tool to Predict the Functional Effect of Amino Acid Substitutions and Indels</article-title>. <source>Bioinformatics</source> <volume>31</volume>, <fpage>2745</fpage>&#x2013;<lpage>2747</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btv195</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choudhury</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mohammad</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Samarth</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Hussain</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rehman</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Islam</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Structural Genomics Approach to Investigate Deleterious Impact of nsSNPs in Conserved Telomere Maintenance Component 1</article-title>. <source>Sci. Rep.</source> <volume>11</volume>, <fpage>10202</fpage>&#x2013;<lpage>10213</lpage>. <pub-id pub-id-type="doi">10.1038/s41598-021-89450-7</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chun</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fay</surname>
<given-names>J.&#x20;C.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Identification of Deleterious Mutations within Three Human Genomes</article-title>. <source>Genome Res.</source> <volume>19</volume>, <fpage>1553</fpage>&#x2013;<lpage>1561</lpage>. <pub-id pub-id-type="doi">10.1101/gr.092619.109</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ciryam</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Tartaglia</surname>
<given-names>G. G.</given-names>
</name>
<name>
<surname>Morimoto</surname>
<given-names>R. I.</given-names>
</name>
<name>
<surname>Dobson</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Vendruscolo</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Widespread Aggregation and Neurodegenerative Diseases Are Associated with Supersaturated Proteins</article-title>. <source>Cel Rep.</source> <volume>5</volume>, <fpage>781</fpage>&#x2013;<lpage>790</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2013.09.043</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>David</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Jacobs</surname>
<given-names>D. J.</given-names>
</name>
</person-group> (<year>2014</year>). &#x201c;<article-title>Principal Component Analysis: a Method for Determining the Essential Dynamics of Proteins</article-title>,&#x201d; in <source>Protein Dynamics</source> (<publisher-loc>Totowa, NJ</publisher-loc>: <publisher-name>Springer</publisher-name>), <fpage>193</fpage>&#x2013;<lpage>226</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-62703-658-0_11</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>DeLano</surname>
<given-names>W. L.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Pymol: An Open-Source Molecular Graphics Tool</article-title>. <source>CCP4 Newsl. Protein Crystallogr.</source> <volume>40</volume>, <fpage>82</fpage>&#x2013;<lpage>92</lpage>. </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eapen</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>I. E.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Myers</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Hansbro</surname>
<given-names>P. M.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Heparin-binding Epidermal Growth Factor (HB-EGF) Drives EMT in Patients with COPD: Implications for Disease Pathogenesis and Novel Therapies</article-title>. <source>Lab. Invest.</source> <volume>99</volume>, <fpage>150</fpage>&#x2013;<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1038/s41374-018-0146-0</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fatima</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mohammad</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Jairajpuri</surname>
<given-names>D. S.</given-names>
</name>
<name>
<surname>Rehman</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Hussain</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Samim</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Identification and Evaluation of Glutathione Conjugate Gamma-L-Glutamyl-L-Cysteine for Improved Drug-Delivery to the Brain</article-title>. <source>J.&#x20;Biomol. Struct. Dyn.</source> <volume>38</volume> (<issue>12</issue>), <fpage>3610</fpage>&#x2013;<lpage>3620</lpage>. <pub-id pub-id-type="doi">10.1080/07391102.2019.1664937</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Habib</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mohammad</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hussain</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Alajmi</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>Rehman</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Impact of Non-synonymous Mutations on the Structure and Function of Telomeric Repeat Binding Factor 1</article-title>. <source>J.&#x20;Biomol. Struct. Dyn.</source>, <fpage>1</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1080/07391102.2021.1922313</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Henke</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Maier</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wallisch</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Boehmer</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lang</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Regulation of the Voltage Gated K&#x2b; Channel Kv1.3 by the Ubiquitin Ligase Nedd4-2 and the Serum and Glucocorticoid Inducible Kinase SGK1</article-title>. <source>J.&#x20;Cel. Physiol.</source> <volume>199</volume>, <fpage>194</fpage>&#x2013;<lpage>199</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.10430</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hubbard</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Barker</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Birney</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Cameron</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2002</year>). <article-title>The Ensembl Genome Database Project</article-title>. <source>Nucleic Acids Res.</source> <volume>30</volume>, <fpage>38</fpage>&#x2013;<lpage>41</lpage>. <pub-id pub-id-type="doi">10.1093/nar/30.1.38</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Humphrey</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Dalke</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Schulten</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>VMD: Visual Molecular Dynamics</article-title>. <source>J.&#x20;Mol. graphics</source> <volume>14</volume>, <fpage>33</fpage>&#x2013;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1016/0263-7855(96)00018-5</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Knowles</surname>
<given-names>T. P. J.</given-names>
</name>
<name>
<surname>Vendruscolo</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dobson</surname>
<given-names>C. M.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>The Amyloid State and its Association with Protein Misfolding Diseases</article-title>. <source>Nat. Rev. Mol. Cel Biol</source> <volume>15</volume>, <fpage>384</fpage>&#x2013;<lpage>396</lpage>. <pub-id pub-id-type="doi">10.1038/nrm3810</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kobayashi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Activation of Serum- and Glucocorticoid-Regulated Protein Kinase by Agonists that Activate Phosphatidylinositide 3-kinase Is Mediated by 3-phosphoinositide-dependent Protein Kinase-1 (PDK1) and PDK2</article-title>. <source>Biochem. J.</source> <volume>339</volume>, <fpage>319</fpage>&#x2013;<lpage>328</lpage>. <pub-id pub-id-type="doi">10.1042/bj3390319</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Henikoff</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>P. C.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Predicting the Effects of Coding Non-synonymous Variants on Protein Function Using the SIFT Algorithm</article-title>. <source>Nat. Protoc.</source> <volume>4</volume>, <fpage>1073</fpage>&#x2013;<lpage>1081</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2009.86</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laimer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hofer</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Fritz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wegenkittl</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lackner</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>MAESTRO - Multi Agent Stability Prediction upon point Mutations</article-title>. <source>BMC bioinformatics</source> <volume>16</volume>, <fpage>116</fpage>. <pub-id pub-id-type="doi">10.1186/s12859-015-0548-6</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Perrotti</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Stournaras</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Colorectal Carcinoma Cells-Regulation of Survival and Growth by SGK1</article-title>. <source>Int. J.&#x20;Biochem. Cel Biol.</source> <volume>42</volume>, <fpage>1571</fpage>&#x2013;<lpage>1575</lpage>. <pub-id pub-id-type="doi">10.1016/j.biocel.2010.05.016</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lobanov</surname>
<given-names>M. Y.</given-names>
</name>
<name>
<surname>Bogatyreva</surname>
<given-names>N. S.</given-names>
</name>
<name>
<surname>Galzitskaya</surname>
<given-names>O. V.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Radius of Gyration as an Indicator of Protein Structure Compactness</article-title>. <source>Mol. Biol.</source> <volume>42</volume>, <fpage>623</fpage>&#x2013;<lpage>628</lpage>. <pub-id pub-id-type="doi">10.1134/s0026893308040195</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>L&#xf3;pez-Ferrando</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Gazzo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>de&#xa0;la&#xa0;Cruz</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Orozco</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Gelp&#xed;</surname>
<given-names>J.&#x20;L.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>PMut: a Web-Based Tool for the Annotation of Pathological Variants on Proteins, 2017 Update</article-title>. <source>Nucleic Acids Res.</source> <volume>45</volume>, <fpage>W222</fpage>&#x2013;<lpage>w228</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkx313</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>Y. T.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>H. Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Epigenetic Regulation in Human Cancer: the Potential Role of Epi-Drug in Cancer Therapy</article-title>. <source>Mol. Cancer</source> <volume>19</volume>, <fpage>79</fpage>&#x2013;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1186/s12943-020-01197-3</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mahmood</surname>
<given-names>M. Q.</given-names>
</name>
<name>
<surname>Ward</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Muller</surname>
<given-names>H. K.</given-names>
</name>
<name>
<surname>Sohal</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Walters</surname>
<given-names>E. H.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Epithelial Mesenchymal Transition (EMT) and Non-small Cell Lung Cancer (NSCLC): a Mutual Association with Airway Disease</article-title>. <source>Med. Oncol.</source> <volume>34</volume>, <fpage>45</fpage>&#x2013;<lpage>10</lpage>. <pub-id pub-id-type="doi">10.1007/s12032-017-0900-y</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohammad</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>F. I.</given-names>
</name>
<name>
<surname>Lobb</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Islam</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ahmad</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Hassan</surname>
<given-names>M. I.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Identification and Evaluation of Bioactive Natural Products as Potential Inhibitors of Human Microtubule Affinity-Regulating Kinase 4 (MARK4)</article-title>. <source>J.&#x20;Biomol. Struct. Dyn.</source> <volume>37</volume>, <fpage>1813</fpage>&#x2013;<lpage>1829</lpage>. <pub-id pub-id-type="doi">10.1080/07391102.2018.1468282</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Myers</surname>
<given-names>J.&#x20;K.</given-names>
</name>
<name>
<surname>Pace</surname>
<given-names>C. N.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Hydrogen Bonding Stabilizes Globular Proteins</article-title>. <source>Biophysical J.</source> <volume>71</volume>, <fpage>2033</fpage>&#x2013;<lpage>2039</lpage>. <pub-id pub-id-type="doi">10.1016/s0006-3495(96)79401-8</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Naqvi</surname>
<given-names>A. A. T.</given-names>
</name>
<name>
<surname>Mohammad</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hasan</surname>
<given-names>G. M.</given-names>
</name>
<name>
<surname>Hassan</surname>
<given-names>M. I.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Advancements in Docking and Molecular Dynamics Simulations towards Ligand-Receptor Interactions and Structure-Function Relationships</article-title>. <source>Ctmc</source> <volume>18</volume>, <fpage>1755</fpage>&#x2013;<lpage>1768</lpage>. <pub-id pub-id-type="doi">10.2174/1568026618666181025114157</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ng</surname>
<given-names>P. C.</given-names>
</name>
<name>
<surname>Henikoff</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Predicting Deleterious Amino Acid Substitutions</article-title>. <source>Genome Res.</source> <volume>11</volume>, <fpage>863</fpage>&#x2013;<lpage>874</lpage>. <pub-id pub-id-type="doi">10.1101/gr.176601</pub-id> </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ng</surname>
<given-names>P. C.</given-names>
</name>
<name>
<surname>Henikoff</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Predicting the Effects of Amino Acid Substitutions on Protein Function</article-title>. <source>Annu. Rev. Genom. Hum. Genet.</source> <volume>7</volume>, <fpage>61</fpage>&#x2013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.genom.7.080505.115630</pub-id> </citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ng</surname>
<given-names>P. C.</given-names>
</name>
<name>
<surname>Henikoff</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>SIFT: Predicting Amino Acid Changes that Affect Protein Function</article-title>. <source>Nucleic Acids Res.</source> <volume>31</volume>, <fpage>3812</fpage>&#x2013;<lpage>3814</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkg509</pub-id> </citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niroula</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Urolagin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Vihinen</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>PON-P2: Prediction Method for Fast and Reliable Identification of Harmful Variants</article-title>. <source>PloS one</source> <volume>10</volume>, <fpage>e0117380</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0117380</pub-id> </citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O&#x27;Keeffe</surname>
<given-names>B. A.</given-names>
</name>
<name>
<surname>Cilia</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Maiyar</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Vaysberg</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Firestone</surname>
<given-names>G. L.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>The Serum- and Glucocorticoid-Induced Protein Kinase-1 (Sgk-1) Mitochondria Connection: Identification of the IF-1 Inhibitor of the F1F0-ATPase as a Mitochondria-specific Binding Target and the Stress-Induced Mitochondrial Localization of Endogenous Sgk-1</article-title>. <source>Biochimie</source> <volume>95</volume>, <fpage>1258</fpage>&#x2013;<lpage>1265</lpage>. <pub-id pub-id-type="doi">10.1016/j.biochi.2013.01.019</pub-id> </citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Overington</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Donnelly</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>&#x160;ali</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Blundell</surname>
<given-names>T. L.</given-names>
</name>
</person-group> (<year>1992</year>). <article-title>Environment-specific Amino Acid Substitution Tables: Tertiary Templates and Prediction of Protein Folds</article-title>. <source>Protein Sci.</source> <volume>1</volume>, <fpage>216</fpage>&#x2013;<lpage>226</lpage>. <pub-id pub-id-type="doi">10.1002/pro.5560010203</pub-id> </citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Paladin</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Piovesan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Tosatto</surname>
<given-names>S. C. E.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>SODA: Prediction of Protein Solubility from Disorder and Aggregation Propensity</article-title>. <volume>45</volume>, <fpage>W236</fpage>&#x2013;<lpage>W240</lpage>.<pub-id pub-id-type="doi">10.1093/nar/gkx412</pub-id> </citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pandurangan</surname>
<given-names>A. P.</given-names>
</name>
<name>
<surname>Ochoa-Monta&#xf1;o</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ascher</surname>
<given-names>D. B.</given-names>
</name>
<name>
<surname>Blundell</surname>
<given-names>T. L.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>SDM: a Server for Predicting Effects of Mutations on Protein Stability</article-title>. <source>Nucleic Acids Res.</source> <volume>45</volume>, <fpage>W229</fpage>&#x2013;<lpage>w235</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkx439</pub-id> </citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Papaleo</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mereghetti</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Fantucci</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Grandori</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>De Gioia</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Free-energy Landscape, Principal Component Analysis, and Structural Clustering to Identify Representative Conformations from Molecular Dynamics Simulations: the Myoglobin Case</article-title>. <source>J.&#x20;Mol. graphics Model.</source> <volume>27</volume>, <fpage>889</fpage>&#x2013;<lpage>899</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmgm.2009.01.006</pub-id> </citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petukh</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kucukkal</surname>
<given-names>T. G.</given-names>
</name>
<name>
<surname>Alexov</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>On Human Disease-Causing Amino Acid Variants: Statistical Study of Sequence and Structural Patterns</article-title>. <source>Hum. Mutat.</source> <volume>36</volume>, <fpage>524</fpage>&#x2013;<lpage>534</lpage>. <pub-id pub-id-type="doi">10.1002/humu.22770</pub-id> </citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pires</surname>
<given-names>D. E. V.</given-names>
</name>
<name>
<surname>Ascher</surname>
<given-names>D. B.</given-names>
</name>
<name>
<surname>Blundell</surname>
<given-names>T. L.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>mCSM: Predicting the Effects of Mutations in Proteins Using Graph-Based Signatures</article-title>. <source>Bioinformatics (Oxford, England)</source> <volume>30</volume>, <fpage>335</fpage>&#x2013;<lpage>342</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btt691</pub-id> </citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>STRUM: Structure-Based Prediction of Protein Stability Changes upon Single-point Mutation</article-title>. <source>Bioinformatics</source> <volume>32</volume>, <fpage>2936</fpage>&#x2013;<lpage>2946</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btw361</pub-id> </citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramensky</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Bork</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Sunyaev</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Human Non-synonymous SNPs: Server and Survey</article-title>. <source>Nucleic Acids Res.</source> <volume>30</volume>, <fpage>3894</fpage>&#x2013;<lpage>3900</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkf493</pub-id> </citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roe</surname>
<given-names>D. R.</given-names>
</name>
<name>
<surname>Cheatham</surname>
<given-names>T. E.</given-names>
<suffix>III</suffix>
</name>
</person-group> (<year>2013</year>). <article-title>PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data</article-title>. <source>J.&#x20;Chem. Theor. Comput.</source> <volume>9</volume>, <fpage>3084</fpage>&#x2013;<lpage>3095</lpage>. <pub-id pub-id-type="doi">10.1021/ct400341p</pub-id> </citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>SGK1 in Human Cancer: Emerging Roles and Mechanisms</article-title>. <source>Front. Oncol.</source> <volume>10</volume>, <fpage>2987</fpage>. <pub-id pub-id-type="doi">10.3389/fonc.2020.608722</pub-id> </citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sekido</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Genomic Abnormalities and Signal Transduction Dysregulation in Malignant Mesothelioma Cells</article-title>. <source>Cancer Sci.</source> <volume>101</volume>, <fpage>1</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1111/j.1349-7006.2009.01336.x</pub-id> </citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shakhnovich</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Abkevich</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Ptitsyn</surname>
<given-names>O.</given-names>
</name>
</person-group> (<year>1996</year>). <article-title>Conserved Residues and the Mechanism of Protein Folding</article-title>. <source>Nature</source> <volume>379</volume>, <fpage>96</fpage>&#x2013;<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1038/379096a0</pub-id> </citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sherry</surname>
<given-names>S. T.</given-names>
</name>
<name>
<surname>Ward</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Kholodov</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Phan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Smigielski</surname>
<given-names>E. M.</given-names>
</name>
<etal/>
</person-group> (<year>2001</year>). <article-title>dbSNP: the NCBI Database of Genetic Variation</article-title>. <source>Nucleic Acids Res.</source> <volume>29</volume>, <fpage>308</fpage>&#x2013;<lpage>311</lpage>. <pub-id pub-id-type="doi">10.1093/nar/29.1.308</pub-id> </citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shihab</surname>
<given-names>H. A.</given-names>
</name>
<name>
<surname>Gough</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>D. N.</given-names>
</name>
<name>
<surname>Stenson</surname>
<given-names>P. D.</given-names>
</name>
<name>
<surname>Barker</surname>
<given-names>G. L. A.</given-names>
</name>
<name>
<surname>Edwards</surname>
<given-names>K. J.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Predicting the Functional, Molecular, and Phenotypic Consequences of Amino Acid Substitutions Using Hidden Markov Models</article-title>. <source>Hum. Mutat.</source> <volume>34</volume>, <fpage>57</fpage>&#x2013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1002/humu.22225</pub-id> </citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Snyder</surname>
<given-names>P. M.</given-names>
</name>
<name>
<surname>Olson</surname>
<given-names>D. R.</given-names>
</name>
<name>
<surname>Thomas</surname>
<given-names>B. C.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Serum and Glucocorticoid-Regulated Kinase Modulates Nedd4-2-Mediated Inhibition of the Epithelial Na&#x2b;Channel</article-title>. <source>J.&#x20;Biol. Chem.</source> <volume>277</volume>, <fpage>5</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.c100623200</pub-id> </citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thal</surname>
<given-names>D. R.</given-names>
</name>
<name>
<surname>Walter</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Saido</surname>
<given-names>T. C.</given-names>
</name>
<name>
<surname>F&#xe4;ndrich</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Neuropathology and Biochemistry of A&#x3b2; and its Aggregates in Alzheimer&#x27;s Disease</article-title>. <source>Acta Neuropathol.</source> <volume>129</volume>, <fpage>167</fpage>&#x2013;<lpage>182</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-014-1375-y</pub-id> </citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Umair</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Khan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mohammad</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Shafie</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Anjum</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Islam</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Impact of Single Amino Acid Substitution on the Structure and Function of TANK&#x2010;binding Kinase&#x2010;1</article-title>. <source>J.&#x20;Cell. Biochem</source> <volume>122</volume>(<issue>10</issue>), <fpage>1475</fpage>&#x2013;<lpage>1490</lpage>. <pub-id pub-id-type="doi">10.1002/jcb.30070</pub-id> </citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waldegger</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Erdel</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nagl</surname>
<given-names>U. O.</given-names>
</name>
<name>
<surname>Barth</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Raber</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Steuer</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>1998</year>). <article-title>Genomic Organization and Chromosomal Localization of the HumanSGKProtein Kinase Gene</article-title>. <source>Genomics</source> <volume>51</volume>, <fpage>299</fpage>&#x2013;<lpage>302</lpage>. <pub-id pub-id-type="doi">10.1006/geno.1998.5258</pub-id> </citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Lehr</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Smallwood</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>T. F.</given-names>
</name>
<name>
<surname>Maley</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Randall</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2007</year>). <article-title>Crystal Structure of the Kinase Domain of Serum and Glucocorticoid-Regulated Kinase 1 in Complex with AMP-PNP</article-title>. <source>Protein Sci.</source> <volume>16</volume>, <fpage>2761</fpage>&#x2013;<lpage>2769</lpage>. <pub-id pub-id-type="doi">10.1110/ps.073161707</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>